These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27413725)

  • 1. Management of HBV and HBV/HDV-Associated Liver Cirrhosis.
    Höner Zu Siederdissen C; Cornberg M
    Visc Med; 2016 Apr; 32(2):86-94. PubMed ID: 27413725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.
    Brancaccio G; Fasano M; Grossi A; Santantonio TA; Gaeta GB
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1071-1076. PubMed ID: 30793345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection.
    Wranke A; Heidrich B; Deterding K; Hupa-Breier KL; Kirschner J; Bremer B; Cornberg M; Wedemeyer H
    Hepatol Int; 2023 Dec; 17(6):1359-1367. PubMed ID: 37789170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapies for hepatitis delta virus infection.
    Loureiro D; Castelnau C; Tout I; Boyer N; Narguet S; Menasria Benazzouz S; Louis Z; Pons-Kerjean N; Giuly N; Marcellin P; Mansouri A; Asselah T
    Liver Int; 2021 Jun; 41 Suppl 1():30-37. PubMed ID: 34155804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.
    Chen LP; Zhao J; Du Y; Han YF; Su T; Zhang HW; Cao GW
    World J Virol; 2012 Dec; 1(6):174-83. PubMed ID: 24175223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of therapy on the outcome of chronic hepatitis B.
    Liaw YF
    Liver Int; 2013 Feb; 33 Suppl 1():111-5. PubMed ID: 23286854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis.
    Honda K; Seike M; Murakami K
    World J Hepatol; 2015 Oct; 7(22):2404-10. PubMed ID: 26464756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma.
    Baran B
    World J Hepatol; 2015 Jul; 7(13):1742-54. PubMed ID: 26167247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea.
    Cho Y; Park S; Park S; Choi W; Kim B; Han H
    Infect Dis Ther; 2023 Oct; 12(10):2387-2403. PubMed ID: 37768482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection.
    Viganò M; Invernizzi F; Grossi G; Lampertico P
    Aliment Pharmacol Ther; 2016 Oct; 44(7):653-61. PubMed ID: 27528410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada.
    Osiowy C; Swidinsky K; Haylock-Jacobs S; Sadler MD; Fung S; Wong D; Minuk GY; Doucette KE; Wong P; Tam E; Cooper C; Ramji A; Ma M; Nudo C; Tsoi K; Coffin CS
    JHEP Rep; 2022 May; 4(5):100461. PubMed ID: 35360523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
    Rapti I; Hadziyannis S
    World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.
    Niro GA; Ippolito AM; Fontana R; Valvano MR; Gioffreda D; Iacobellis A; Merla A; Durazzo M; Lotti G; Di Mauro L; Andriulli A
    J Viral Hepat; 2013 Jul; 20(7):502-9. PubMed ID: 23730844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.
    Tawada A; Kanda T; Imazeki F; Yokosuka O
    Hepatol Int; 2016 Jul; 10(4):574-93. PubMed ID: 27026375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.